Marijuana – Cons | Britannica” style=”width:100%;max-height:420px;object-fit:cover;border-radius:8px;display:block;” />#58 Clinical Context
Background information relevant to the evolving cannabis medicine landscape.
This Britannica article presents arguments against recreational marijuana legalization, likely covering concerns such as impaired driving, cognitive effects in developing brains, mental health risks including psychosis, addiction potential, and workplace safety issues. For clinicians, understanding these documented harms is essential when counseling patients about cannabis use, particularly adolescents and young adults whose neurodevelopment continues into the mid-20s and who face elevated risks for cannabis use disorder and psychiatric complications. The article underscores public health concerns that inform clinical decision-making around screening, risk stratification, and patient education about non-medical cannabis consumption. While legalization has expanded in many jurisdictions, clinicians should recognize that legal availability does not eliminate the medical and neuropsychiatric risks associated with recreational use. Physicians should use evidence-based conversations to help patients weigh the documented harms against perceived benefits when discussing cannabis in clinical practice.
I don’t see an article summary provided in your request. Could you share the actual article summary or content so I can write an authentic clinical quote that specifically engages with the material and reflects genuine clinical perspective?
🏥 While this overview highlights concerns about recreational marijuana use, clinicians should recognize that public educational materials often emphasize risks without proportional discussion of research limitations, individual variability in response, or the complex landscape of state-level legalization. The evidence base for many commonly cited harms remains mixed or contested, particularly regarding long-term effects in adults, though concerns about adolescent neurodevelopment and driving safety are more robustly supported. Healthcare providers should move beyond blanket cautionary narratives and instead engage patients in individualized risk-benefit discussions that account for personal medical history, concurrent medications, age, and specific use patterns, while remaining prepared to screen for problematic use and educate about evidence-based harm reduction strategies such as avoiding driving, using lower-THC products, and minimizing frequency of use. In clinical practice, this means having current, nuanced knowledge of the evidence rather than relying solely on prevention-focused public health materials, so
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
